Details of Drug-Metabolizing Enzyme (DME)
| General Information of DME (ID: DME1677) | |||||
|---|---|---|---|---|---|
| DME Name | Beta-glycosidase (glyB), Parabacteroides distasonis | ||||
| Synonyms | Isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase; Peptidoglycan hydrolase; CF162_08980 | ||||
| Gene Name | glyB | ||||
| UniProt ID | |||||
| EC Number | EC: 3.2.1.- (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Parabacteroides distasonis (Click to Show/Hide the Complete Species Lineage) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Sequence |
MRTFSKKKKLPRLLTLCGAVAVSALLGGCGQSGVPAESFDRSDYYTRGIGSYPGDPGEDF
SPSLRPDYSTYRNIALLRSAYNSSSYDYNLTAQLVTDGVISDKQPQYLDLSTQNGDIARR EREWMIDQGPYSRNAVTGEDAYFLFTLNNWKEKADKVQFRGSVAYDENKIKDGYEIVCEG SNDGNTWTELAALKGKGMPGKASKYKAHSDPNKNSWDPGTLPTRMLNETLTFDQPGEYAY YRMRLKMEGAAYWAFFEMNFYNQDKLIDLLPSKFFNSAWMSATTGEEWVYVDLGSQSEFD KVKLHWINKAIKGKIQVSDDAKQWVDIANLPGGDANLDEIKLKGKGRYVRVWMEQPANDG RYILSEIEVMGKGGLLAQPAAAPAATKDEIRLSGGNWKVQRASEVTASGEEISKPSFSPE NWIVATVPGTVLSSYKNIGAIPNPNYADNLMQISESFFNSNFWYRDEFEVPEGFKQDRLF LNFDGINWKANVYLNGNKIGRIEGAFIRGVFDVTDRVVPGKNVVAVEIIKNEHIGAIKEK CEKNTDFNGGILGADNPTFHASIGWDWISTIRGRNIGIWDDVYLTSTGKVTIQDPFVQVV LPLPDTTSATLTPEVIVKNHDAAPVKGVLTGKIGDITFEQPVELAANEEKTVTFDPNSFS QLKVQNPRLWWPKGYGSPYLYDANFTFKVGDKVSDSEDFKVGIRQMTFNENNSILSLFIN GRRFIGRGGNWGFGESNLNYRGREYDIAVAYHADMNFTMMRNWVGQIGDKELYEACDRHG IMIWQDFWLANPSDGPDPYDPEMFIANAEDYVKRFRNHASIGIYCGRNEGFPPEQIDKAL RRIVKEDHPGLHYISSSADEVVSGHGPYRALPVKEYFSLKNGSDKFHSERGMPNVMNYES LVRTFSPEALWPQNAQWGQHDYTMEGAQSCASFNAIIEKGFGKPNNAKEFADLAQWVNYD GYRGMFESRSLNRKGLLLWMTHPAWPSMVWQTYDYYFEPTAAYFGCKKASEPLHIQWNPV TDEIEVVNYSAGVRNGLTAKAQIINMDGSISWENEVSVDSKEDTTNKCMKLDFPASVSSA HFVKLTLTENGKIVSDNFYLRGVEEGNYQALREMPKVTLRSNVATNKGNDGTWTATATLE NTSSTPALMIRVNVIGEKDGQQFLPMFYSDNYFSLLPGEKKEINIHWKDVDTRGEAPKVV ISGYNVN |
||||
| Function | This enzyme catalyzes the hydrolysis of substrates containing beta-glycoside. | ||||
| Full List of Drug(s) Metabolized by This DME | |||||
|---|---|---|---|---|---|
| Drugs in Phase 2 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
Remogliflozin etabonate |
Drug Info | Phase 2 | Type-1/2 diabetes | ICD11: 5A10-5A11 | [1] |
| Preclinical/investigative Agents | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
K-6015 |
Drug Info | Investigative | Campylobacter gastroenteritis | ICD11: 1A06 | [2] |
| Full List of Metabolic Reactions (MR) Catalyzed by This DME | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

